In vivo findings from syngeneic models of metastasis indicate that GPVI promotes metastasis in melanoma and lung cancer, and inhibition of GPVI offers a completely new therapeutic approach with minimal bleeding [24, 25]. The gene discussed is GP6; the disease is lung cancer.